Philips Gains FDA Clearance for AI Ultrasound Upgrade
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Healthcare Innovation Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody NSCLC Oncology oncology innovation oncology research Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
AMSTERDAM, Netherlands, June 2, 2026 Royal Philips has received U.S. FDA 510(k) clearance and CE Mark approval for Elevate...
FREMONT, California, USA, June 2, 2026 Alamar Biosciences has unveiled its NULISAâ„¢ Dried Blood Spot (DBS) Extraction Kit, a...
DUBLIN, Ireland, April 9, 2026 Jazz Pharmaceuticals plc has announced the presentation of six scientific abstracts, including one oral...
